Furthermore, we show that knocking out endogenous SLAMF6 in AML cells by CRISPR–Cas9 induces T cell activation and killing, demonstrating that SLAMF6 upregulation is an immune evasion mechanism that protects AML cells from T cell-mediated killing. This evidence concerns the gene SLAMF6 and acute myeloid leukemia.